ArticleJournal of nanobiotechnology2021

A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway.

Yu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.